<- Go Home
Enfusion, Inc.
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also provides Accounting/General Ledger System, a proper double-entry ledger that automates the posting of general ledger journal entries for all cash and securities transactions for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois. As of April 21, 2025, Enfusion, Inc. operates as a subsidiary of Clearwater Analytics Holdings, Inc.
Market Cap
$1.0B
Volume
392.9K
Cash and Equivalents
$54.5M
EBITDA
$13.6M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$136.7M
Profit Margin
67.82%
52 Week High
$11.80
52 Week Low
$7.83
Dividend
N/A
Price / Book Value
13.91
Price / Earnings
356.07
Price / Tangible Book Value
13.91
Enterprise Value
$1.0B
Enterprise Value / EBITDA
45.88
Operating Income
$7.1M
Return on Equity
4.42%
Return on Assets
3.50
Cash and Short Term Investments
$54.5M
Debt
$20.3M
Equity
$99.5M
Revenue
$201.6M
Unlevered FCF
$24.7M
Sector
Software
Category
N/A